Uveal Melanoma
Uveal melanoma survival predicted by monosomy 3 and largest tumor diameter
Published in Cancer Weekly, November 14th, 2006
"Uveal melanoma is one of the most frequently occurring primary intraocular malignancies in the Western world. Cytogenetically these tumors are characterized by typical chromosomal losses and gains, such as loss of 1p, 3, and 6q and gain of 6p and 8q," scientists writing in the journal Investigative Ophthalmology & Visual Science reported.
"Whereas most studies focus on known aberrations, in this one, cytogenetic changes were characterized and correlated with clinical and histopathologic parameters," explained E. Kilic and colleagues, Erasmus Medical Center....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-11-14)
More Articles from Cancer Weekly
- Apoptosis
Ewing sarcoma cell apoptosis induced by arsenic trioxide - Breast Cancer
Breast cancer treated by butyroyloxymethyl-diethyl phosphate and doxorubicin - Diet & Nutrition
Benign prostatic hyperplasia risk reduced with intake of selected micronutrients - Diet & Nutrition
Cancer survival might depend on season of diagnosis and sunlight exposure - Drug Development
Randomized approaches might decrease high failure rate for oncological drugs in phase III trials - Cancer Gene Therapy
Dankook University, Institute of Nanosensor and Biotechnology details research in cancer gene therapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
